Integrated Care And Oncology Expansion Will Shape India's Future

Published
30 Dec 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
₹1,831.36
1.1% undervalued intrinsic discount
14 Aug
₹1,812.00
Loading
1Y
53.8%
7D
1.9%

Author's Valuation

₹1.8k

1.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on06 Aug 25
Fair value Increased 8.44%

The analyst price target for Narayana Hrudayalaya has increased to ₹1790, driven by higher consensus revenue growth forecasts and a lower expected future P/E multiple. What's in the News Board meeting scheduled to approve unaudited Q1 FY26 results and consider revised proposal to raise capital via debt securities on a private placement basis, subject to shareholder approval in the upcoming AGM.

Shared on15 Jul 25
Fair value Increased 17%

Despite a reduction in consensus revenue growth forecasts, Narayana Hrudayalaya’s higher future P/E suggests improved market sentiment or expectations for profitability, driving the analyst price target up from ₹1443 to ₹1689. WHAT'S IN THE NEWS Announced annual dividend of INR 4.50 per share.

Shared on12 Mar 25
Fair value Decreased 17%

AnalystConsensusTarget has decreased future PE multiple from 41.4x to 35.3x and decreased shares outstanding growth rate from 0.0% to -0.0%.